BVF Inc’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-361,406
Closed -$643K 62
2024
Q1
$643K Sell
361,406
-1,009,541
-74% -$1.8M 0.02% 61
2023
Q4
$2.41M Hold
1,370,947
0.06% 62
2023
Q3
$2M Hold
1,370,947
0.05% 62
2023
Q2
$3.14M Hold
1,370,947
0.09% 59
2023
Q1
$1.25M Hold
1,370,947
0.05% 67
2022
Q4
$1.17M Hold
1,370,947
0.05% 72
2022
Q3
$1.12M Hold
1,370,947
0.05% 73
2022
Q2
$1.36M Hold
1,370,947
0.07% 72
2022
Q1
$2.25M Hold
1,370,947
0.09% 74
2021
Q4
$3.3M Hold
1,370,947
0.12% 71
2021
Q3
$6.64M Sell
1,370,947
-2,307,679
-63% -$11.2M 0.26% 62
2021
Q2
$9.82M Buy
3,678,626
+449,200
+14% +$1.2M 0.37% 50
2021
Q1
$9.95M Buy
3,229,426
+1,285,714
+66% +$3.96M 0.37% 50
2020
Q4
$6.92M Buy
1,943,712
+200,000
+11% +$712K 0.27% 50
2020
Q3
$6.99M Buy
1,743,712
+1,600
+0.1% +$6.42K 0.38% 49
2020
Q2
$4.74M Sell
1,742,112
-414,628
-19% -$1.13M 0.29% 48
2020
Q1
$4.55M Buy
2,156,740
+529,172
+33% +$1.12M 0.42% 42
2019
Q4
$8.85M Sell
1,627,568
-1,419,587
-47% -$7.72M 0.67% 33
2019
Q3
$9.17M Buy
3,047,155
+272,405
+10% +$820K 0.96% 30
2019
Q2
$10.4M Buy
2,774,750
+665,408
+32% +$2.49M 1.13% 28
2019
Q1
$8.48M Buy
2,109,342
+218,835
+12% +$880K 0.95% 34
2018
Q4
$6.94M Hold
1,890,507
0.91% 32
2018
Q3
$16.2M Hold
1,890,507
1.43% 22
2018
Q2
$20.8M Sell
1,890,507
-63,747
-3% -$700K 2.03% 20
2018
Q1
$22.5M Buy
1,954,254
+1,494,858
+325% +$17.2M 2.28% 17
2017
Q4
$4.76M Hold
459,396
0.57% 34
2017
Q3
$7.32M Buy
459,396
+185,200
+68% +$2.95M 0.93% 29
2017
Q2
$3.32M Buy
+274,196
New +$3.32M 0.52% 29